Yatharth Hospital is a leading super-specialty hospital chain in Delhi NCR. The company is offering an IPO of 10,000,000 equity shares at a price band of ₹285-₹300 per share. The IPO opens on July 26, 2023, and closes on July 28, 2023.
The company has a strong track record of financial performance. Revenue has grown at a CAGR of 30% over the past four years, and profit after tax has grown at a CAGR of 60% over the same period. The company has a well-diversified patient mix, with a strong focus on the high-end private pay segment.
The IPO is well-priced, with a P/E ratio of 20x FY23 earnings. This is in line with the valuations of other hospital chains in the same sector.
There are some risks associated with the investment, such as the potential for rising costs and competition from other hospitals. However, the company has a strong management team with a proven track record, and it is well-positioned to grow in the long term.
Key Takeaways for Investors
- The company has a strong track record of financial performance.
- The IPO is well-priced.
- The company has a well-diversified patient mix.
- The company is well-positioned to grow in the long term.
However, there are some risks associated with the investment, such as the potential for rising costs and competition from other hospitals.
Overall, the Yatharth Hospital IPO is a good investment for investors with a long-term horizon.
Should You Invest in the Yatharth Hospital IPO?
The Yatharth Hospital IPO is a good investment for investors who are looking for exposure to the growing healthcare sector in India. The company has a strong track record of financial performance and is well-positioned to grow in the long term. However, there are some risks associated with the investment, such as the potential for rising costs and competition from other hospitals.
Investors should carefully consider their investment objectives and risk tolerance before investing in the Yatharth Hospital IPO.
❤️